Detalhe da pesquisa
1.
Antigen dominance hierarchies shape TCF1+ progenitor CD8 T cell phenotypes in tumors.
Cell
; 184(19): 4996-5014.e26, 2021 09 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34534464
2.
Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy.
Cell
; 182(3): 655-671.e22, 2020 08 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32603654
3.
Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 Blockade.
Cell
; 173(3): 624-633.e8, 2018 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29656892
4.
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade.
Cell
; 175(4): 984-997.e24, 2018 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30388455
5.
Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab.
Cell
; 171(4): 934-949.e16, 2017 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29033130
6.
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy.
Cell
; 170(6): 1109-1119.e10, 2017 Sep 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28886381
7.
Author Correction: Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade.
Nat Immunol
; 20(11): 1556, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31582823
8.
Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade.
Nat Immunol
; 20(3): 326-336, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30778252
9.
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy.
Cell
; 174(4): 1031-1032, 2018 08 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30096300
10.
Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma.
N Engl J Med
; 386(1): 24-34, 2022 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34986285
11.
Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease.
Blood
; 141(15): 1817-1830, 2023 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36706355
12.
Outcomes of High-Grade Immune Checkpoint Inhibitor Hepatitis in Hospitalized and Nonhospitalized Patients.
Clin Gastroenterol Hepatol
; 2024 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38401693
13.
Ziv-aflibercept plus pembrolizumab in patients with advanced melanoma resistant to anti-PD-1 treatment.
Cancer Immunol Immunother
; 73(1): 17, 2024 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38236249
14.
Profiling of Natural Killer Interactions With Cancer Cells Using Mass Cytometry.
Lab Invest
; 103(8): 100174, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37169083
15.
Immune checkpoint inhibitor gastritis is often associated with concomitant enterocolitis, which impacts the clinical course.
Cancer
; 129(3): 367-375, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36377339
16.
Mechanical checkpoint regulates monocyte differentiation in fibrotic niches.
Nat Mater
; 21(8): 939-950, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35817965
17.
Effect of corticosteroid dosing on outcomes in high-grade immune checkpoint inhibitor hepatitis.
Hepatology
; 75(3): 531-540, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34709662
18.
Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation.
Blood
; 137(23): 3212-3217, 2021 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33720354
19.
Spatial signatures identify immune escape via PD-1 as a defining feature of T-cell/histiocyte-rich large B-cell lymphoma.
Blood
; 137(10): 1353-1364, 2021 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32871584
20.
Early Liver Specialist Consultation is Associated With Faster Biochemical Resolution of Severe Immune Checkpoint Inhibitor-Induced Hepatitis.
J Natl Compr Canc Netw
; 21(6): 617-626.e3, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37308118